Galapagos Articles
Roche pulls out of fibrosis alliance with Galapagos
11 March 2013
News briefs from Alimera on Iluvien and Xencor on Xtend; Galapagos milestone and acquisition
17 January 2013
Galapagos unit in CNS discovery deal with Ono Pharma
3 September 2012
GSK exercises option for Galapagos drug candidates
21 February 2012
Servier and Galapagos in 260 million-euro oncology deal
4 October 2011
Merck & Co posts fourth-quarter 2010 loss of $531 million as a result of charges; drops alliance with Galapagos
4 February 2011
Galapagos in deal with Johnson & Johnson unit for oncology target in 33.5 million-euro deal; US FDA delays J&J’s tapentadol ER
5 October 2010
GlaxoSmithKline sells Croatian research center to Galapagos, names new CFO and enters supply deal with Lonza; EMEA update on Avandia and Pandemrix
9 September 2010
Showing 1-14 of 14 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
